AbbVie seeks FDA approval for Pivekimab Sunirine to treat rare, aggressive blood cancer
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
ANVIMO will be available in dosages of 240 mg and 480 mg
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Emcure has launched an awareness campaign to help spread the word about male anemia
Modernization and supply chain diversity drive new growth
Subscribe To Our Newsletter & Stay Updated